Your browser doesn't support javascript.
loading
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.
Vliek, Sonja; Hilbers, Florentine S; van Werkhoven, Erik; Mandjes, Ingrid; Kessels, Rob; Kleiterp, Sieta; Lips, Esther H; Mulder, Lennart; Kayembe, Mutamba T; Loo, Claudette E; Russell, Nicola S; Vrancken Peeters, Marie-Jeanne T F D; Holtkamp, Marjo J; Schot, Margaret; Baars, Joke W; Honkoop, Aafke H; Vulink, Annelie J E; Imholz, Alex L T; Vrijaldenhoven, Suzan; van den Berkmortel, Franchette W P J; Meerum Terwogt, Jetske M; Schrama, Jolanda G; Kuijer, Philomeen; Kroep, Judith R; van der Padt-Pruijsten, Annemieke; Wesseling, Jelle; Sonke, Gabe S; Gilhuijs, Kenneth G A; Jager, Agnes; Nederlof, Petra; Linn, Sabine C.
Afiliación
  • Vliek S; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hilbers FS; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van Werkhoven E; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Mandjes I; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kessels R; HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Kleiterp S; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Lips EH; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Mulder L; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kayembe MT; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Loo CE; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Russell NS; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Vrancken Peeters MTFD; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Holtkamp MJ; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Schot M; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Baars JW; Department of Surgery, Amsterdam University Medical center, Amsterdam, The Netherlands.
  • Honkoop AH; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Vulink AJE; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Imholz ALT; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Vrijaldenhoven S; Department of Internal Medicine, Isala Klinieken, Zwolle, The Netherlands.
  • van den Berkmortel FWPJ; Division of Medical Oncology, Reinier de Graaf Hospital, Delft, The Netherlands.
  • Meerum Terwogt JM; Department of Internal Medicine, Deventer Ziekenhuis, Deventer, The Netherlands.
  • Schrama JG; Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands.
  • Kuijer P; Department of Oncology, Zuyderland Medisch Centrum, Heerlen-Geleen, The Netherlands.
  • Kroep JR; Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
  • van der Padt-Pruijsten A; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands.
  • Wesseling J; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands.
  • Sonke GS; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Gilhuijs KGA; Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands.
  • Jager A; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Nederlof P; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Linn SC; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
NPJ Breast Cancer ; 9(1): 75, 2023 Sep 09.
Article en En | MEDLINE | ID: mdl-37689749
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: NPJ Breast Cancer Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: NPJ Breast Cancer Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos